Are Generic Manufacturers Liable For Failure To Warn Claims? Supreme Court Seeks Government's Opinion
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva and other generic manufacturers seek Supreme Court review of an appeals court finding that they are responsible for labeling on generic versions of Reglan.
You may also be interested in...
Generic Manufacturers Should Be Liable For Inadequate Label Warnings, Government Says
The Solicitor General advises the Supreme Court not to take up a case involving failure-to-warn claims for the heartburn drug Reglan.
Generic Manufacturers Should Be Liable For Inadequate Label Warnings, Government Says
The Solicitor General advises the Supreme Court not to take up a case involving failure-to-warn claims for the heartburn drug Reglan.
Supreme Court Again Asked To Address Generic Firms' Liability For Inadequate Warning Labels
Actavis is making a second appeal to the Supreme Court to consider whether a generic manufacturer can be sued for failing to add safety information to its labeling that is not in the brand's label